DSM and Sanquin sign manufacturing agreement for factor IX antibody

10/24/2013 | Genetic Engineering & Biotechnology News

Sanquin Blood Supply Foundation and DSM Pharmaceutical Products have signed a commercial manufacturing agreement to produce a monoclonal antibody for the recovery and purification of coagulation factor IX from human blood. Production will take place at a DSM Biologics facility in the Netherlands.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Abbott
Santa Clara, CA
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA